Companies: 10,795·Total market cap: $144.5T
Blueprint Medicines Corporation

Blueprint Medicines Corporation

BPMCNASDAQHealthcare
$129.46
+$0.18(+0.14%)
Market Cap$8.4B
P/E Ratio
52W High$129.55
52W Low$73.04
Overview

Blueprint Medicines Corporation (BPMC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BPMC · as of Jun 9, 2026

Key Statistics

EPS (TTM)bpmc eps ttm · bpmc earnings per shareEarnings history
PE Ratio (TTM)bpmc pe ratio ttm · bpmc price to earningsPE Ratio deep dive
Revenue (TTM)bpmc revenue ttm · bpmc annual revenueFull revenue history
Dividend YieldNo Dividenddoes bpmc pay dividends · bpmc dividend yieldDividend history
Shares Outstandingbpmc shares outstanding · bpmc floatShares outstanding history
Next EarningsTBAbpmc earnings date · bpmc next earningsEarnings history

About Blueprint Medicines Corporation

CEOKathryn Haviland
IPO DateApr 30, 2015
Employees682
CountryUS

Blueprint Medicines Corporation is a biopharmaceutical company dedicated to pioneering precision therapies. Its core mission involves developing innovative treatments for various cancers and specific …

what is blueprint medicines corporation · bpmc stock overview · blueprint medicines corporation company profile · who is blueprint medicines corporation ceo · bpmc NASDAQ · blueprint medicines corporation headquarters · blueprint medicines corporation business segments

About Stock Overview & Key Data

Blueprint Medicines Corporation (BPMC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 30, 2015. As of the latest trading session, BPMC stock price is $129.46, with a market capitalization of $8.4B. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Blueprint Medicines Corporation (BPMC) stock price is $129.46. The stock is traded on NASDAQ under the ticker symbol BPMC. The 52-week range is $73.04 – $129.55.

BPMC stock priceBPMC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice